Cargando…
Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia
Treatment with dimethyl fumarate (DMF) leads to lymphopenia and infectious complications in a subset of patients with multiple sclerosis (MS). Here, we aimed to reveal immune markers of DMF‐associated lymphopenia. This prospective observational study longitudinally assessed 31 individuals with MS by...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314128/ https://www.ncbi.nlm.nih.gov/pubmed/35170072 http://dx.doi.org/10.1002/ana.26328 |
_version_ | 1784754244956454912 |
---|---|
author | Diebold, Martin Galli, Edoardo Kopf, Andreas Sanderson, Nicholas Callegari, Ilaria Ingelfinger, Florian Núñez, Nicolás Gonzalo Benkert, Pascal Kappos, Ludwig Kuhle, Jens Becher, Burkhard Claassen, Manfred Derfuss, Tobias |
author_facet | Diebold, Martin Galli, Edoardo Kopf, Andreas Sanderson, Nicholas Callegari, Ilaria Ingelfinger, Florian Núñez, Nicolás Gonzalo Benkert, Pascal Kappos, Ludwig Kuhle, Jens Becher, Burkhard Claassen, Manfred Derfuss, Tobias |
author_sort | Diebold, Martin |
collection | PubMed |
description | Treatment with dimethyl fumarate (DMF) leads to lymphopenia and infectious complications in a subset of patients with multiple sclerosis (MS). Here, we aimed to reveal immune markers of DMF‐associated lymphopenia. This prospective observational study longitudinally assessed 31 individuals with MS by single‐cell mass cytometry before and after 12 and 48 weeks of DMF therapy. Employing a neural network‐based representation learning approach, we identified a CCR4‐expressing T helper cell population negatively associated with relevant lymphopenia. CCR4‐expressing T helper cells represent a candidate prognostic biomarker for the development of relevant lymphopenia in patients undergoing DMF treatment. ANN NEUROL 2022;91:676–681 |
format | Online Article Text |
id | pubmed-9314128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93141282022-07-30 Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia Diebold, Martin Galli, Edoardo Kopf, Andreas Sanderson, Nicholas Callegari, Ilaria Ingelfinger, Florian Núñez, Nicolás Gonzalo Benkert, Pascal Kappos, Ludwig Kuhle, Jens Becher, Burkhard Claassen, Manfred Derfuss, Tobias Ann Neurol Brief Communications Treatment with dimethyl fumarate (DMF) leads to lymphopenia and infectious complications in a subset of patients with multiple sclerosis (MS). Here, we aimed to reveal immune markers of DMF‐associated lymphopenia. This prospective observational study longitudinally assessed 31 individuals with MS by single‐cell mass cytometry before and after 12 and 48 weeks of DMF therapy. Employing a neural network‐based representation learning approach, we identified a CCR4‐expressing T helper cell population negatively associated with relevant lymphopenia. CCR4‐expressing T helper cells represent a candidate prognostic biomarker for the development of relevant lymphopenia in patients undergoing DMF treatment. ANN NEUROL 2022;91:676–681 John Wiley & Sons, Inc. 2022-03-04 2022-05 /pmc/articles/PMC9314128/ /pubmed/35170072 http://dx.doi.org/10.1002/ana.26328 Text en © 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Communications Diebold, Martin Galli, Edoardo Kopf, Andreas Sanderson, Nicholas Callegari, Ilaria Ingelfinger, Florian Núñez, Nicolás Gonzalo Benkert, Pascal Kappos, Ludwig Kuhle, Jens Becher, Burkhard Claassen, Manfred Derfuss, Tobias Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia |
title | Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia |
title_full | Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia |
title_fullStr | Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia |
title_full_unstemmed | Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia |
title_short | Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia |
title_sort | immunological predictors of dimethyl fumarate‐induced lymphopenia |
topic | Brief Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314128/ https://www.ncbi.nlm.nih.gov/pubmed/35170072 http://dx.doi.org/10.1002/ana.26328 |
work_keys_str_mv | AT dieboldmartin immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT galliedoardo immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT kopfandreas immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT sandersonnicholas immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT callegariilaria immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT ingelfingerflorian immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT nuneznicolasgonzalo immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT benkertpascal immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT kapposludwig immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT kuhlejens immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT becherburkhard immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT claassenmanfred immunologicalpredictorsofdimethylfumarateinducedlymphopenia AT derfusstobias immunologicalpredictorsofdimethylfumarateinducedlymphopenia |